OpenLB
Open Library of Bioscience
Advanced Search
PloS one
2022;17 (12): e0269760.

E-cigarette use and respiratory symptoms in residents of the United States: A BRFSS report.

Marcia H Varella, Olyn A Andrade, Sydney M Shaffer, Grettel Castro, Pura Rodriguez, Noël C Barengo, Juan M Acuna
Author Information
  1. Marcia H Varella: Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States of America.
  2. Olyn A Andrade: American University of Antigua College of Medicine, United States of America.
  3. Sydney M Shaffer: American University of Antigua College of Medicine, United States of America.
  4. Grettel Castro: Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States of America.
  5. Pura Rodriguez: Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States of America.
  6. Noël C Barengo: Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States of America.
  7. Juan M Acuna: Department of Epidemiology and Aw 8474000331 R-DISC, Khalifa University, Abu Dhabi, United Arab Emirates. ORCID
PMID: 36454742 DOI: 10.1371/journal.pone.0269760

Abstract

PURPOSE: E-cigarettes are the most common type of electronic nicotine delivery system in the United States. E-cigarettes contain numerous toxic compounds that has been shown to induce severe structural damage to the airways. The objective of this study is to assess if there is an association between e-cigarette use and respiratory symptoms in adults in the US as reported in the BRFSS.
METHODS: We analyzed data from 18,079 adults, 18-44 years, who participated at the Behavioral Risk Factor Surveillance System (BRFSS) in the year 2017. e-cigarette smoking status was categorized as current everyday user, current some days user, former smoker, and never smoker. The frequency of any respiratory symptoms (cough, phlegm, or shortness of breath) was compared. Unadjusted and adjusted logistic regression analysis were used to calculate odds ratios (OR) and 95% confidence intervals (CI).
RESULTS: The BRFSS reported prevalence of smoking e-cigarettes was 6%. About 28% of the participants reported any of the respiratory symptoms assessed. The frequency of reported respiratory symptoms was highest among current some days e-cigarette users (45%). After adjusting for selected participant's demographic, socio-economic, and behavioral characteristics, and asthma and COPD status, the odds of reporting respiratory symptoms increased by 49% among those who use e-cigarettes some days (OR 1.49; 95% CI: 1.06-2.11), and by 29% among those who were former users (OR 1.29; 95% CI: 1.07-1.55) compared with those who never used e-cigarettes. No statistically significant association was found for those who used e-cigarettes every day (OR 1.41; 95% CI 0.96-2.08).
CONCLUSION: E-cigarettes cannot be considered as a safe alternative to aid quitting use of combustible traditional cigarettes. Cohort studies may shed more evidence on the association between e-cigarette use and respiratory diseases.

References

  1. Biomed Res Int. 2019 Dec 19;2019:1386710 [PMID: 31950030]
  2. MMWR Surveill Summ. 2022 Mar 11;71(5):1-29 [PMID: 35271557]
  3. Ann Intern Med. 2018 Oct 2;169(7):429-438 [PMID: 30167658]
  4. BMC Public Health. 2014 Nov 08;14:1159 [PMID: 25380748]
  5. Eur Respir J. 2021 Jan 21;57(1): [PMID: 33154031]
  6. Am J Respir Crit Care Med. 2018 Feb 15;197(4):492-501 [PMID: 29053025]
  7. Rev Invest Clin. 2019;71(1):17-27 [PMID: 30810544]
  8. BMC Pulm Med. 2019 Oct 16;19(1):180 [PMID: 31619218]
  9. JAMA Netw Open. 2020 Oct 1;3(10):e2020671 [PMID: 33048131]
  10. J Public Health Policy. 2011 Feb;32(1):16-31 [PMID: 21150942]
  11. JAMA Netw Open. 2020 Jan 3;3(1):e1920255 [PMID: 32003818]
  12. Environ Health Perspect. 2016 Jun;124(6):733-9 [PMID: 26642857]
  13. Am J Prev Med. 2020 Feb;58(2):182-190 [PMID: 31859175]
  14. JAMA Pediatr. 2016 Jan;170(1):89-91 [PMID: 26551991]
  15. JAMA Netw Open. 2020 Nov 2;3(11):e2020816 [PMID: 33180127]
  16. Cochrane Database Syst Rev. 2021 Apr 29;4:CD010216 [PMID: 33913154]
  17. Ann Intern Med. 2019 Jan 1;170(1):76-79 [PMID: 30304466]
  18. Public Health Rep. 2020 Nov/Dec;135(6):785-795 [PMID: 32972319]
  19. Am J Respir Crit Care Med. 2017 Apr 15;195(8):1043-1049 [PMID: 27806211]

MeSH Term

Adult
United States
Humans
Vaping
Electronic Nicotine Delivery Systems
Behavioral Risk Factor Surveillance System
Asthma
Cough
Journal Article
Article has an altmetric score of 4

Word Cloud

Created with Highcharts 10.0.0respiratorysymptomsuse1reportedBRFSSOR95%e-cigarettesE-cigarettesassociatione-cigarettecurrentdaysusedamongUnitedadultsE-cigarettesmokingstatususerformersmokerneverfrequencycomparedoddsCIusersCI:PURPOSE:commontypeelectronicnicotinedeliverysystemStatescontainnumeroustoxiccompoundsshowninduceseverestructuraldamageairwaysobjectivestudyassessUSMETHODS:analyzeddata1807918-44yearsparticipatedBehavioralRiskFactorSurveillanceSystemyear2017categorizedeverydaycoughphlegmshortnessbreathUnadjustedadjustedlogisticregressionanalysiscalculateratiosconfidenceintervalsRESULTS:prevalence6%28%participantsassessedhighest45%adjustingselectedparticipant'sdemographicsocio-economicbehavioralcharacteristicsasthmaCOPDreportingincreased49%4906-21129%2907-155statisticallysignificantfoundeveryday41096-208CONCLUSION:consideredsafealternativeaidquittingcombustibletraditionalcigarettesCohortstudiesmayshedevidencediseasesresidentsStates:report

Similar Articles

Cited By